Advertisement
Advertisement
U.S. markets open in 6 hours 39 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Teva Pharmaceutical Industries Ltd (TEV.MU)

Munich - Munich Delayed Price. Currency in EUR
9.50-0.06 (-0.63%)
As of 08:00AM CEST. Market open.
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
15,017,000
14,925,000
15,878,000
16,658,000
16,887,000
Cost of Revenue
8,200,000
7,952,000
8,284,000
8,933,000
9,351,000
Gross Profit
6,817,000
6,973,000
7,594,000
7,726,000
7,537,000
Operating Expense
4,267,000
4,283,000
4,495,000
4,668,000
4,816,000
Operating Income
2,550,000
2,690,000
3,099,000
3,058,000
2,721,000
Net Non Operating Interest Income Expense
-1,051,000
-966,000
-1,058,000
-963,000
-822,000
Other Income Expense
-3,602,000
-4,789,000
-1,384,000
-6,500,000
-3,164,000
Pretax Income
-2,106,000
-3,065,000
658,000
-4,406,000
-1,265,000
Tax Provision
226,000
-638,000
211,000
-168,000
-278,000
Earnings from Equity Interest Net of Tax
1,000
21,000
9,000
138,000
-13,000
Net Income Common Stockholders
-2,234,000
-2,353,000
417,000
-3,990,000
-999,000
Diluted NI Available to Com Stockholders
-2,234,000
-2,353,000
417,000
-3,990,000
-999,000
Basic EPS
-
-2.12
0.38
-3.64
-0.91
Diluted EPS
-
-2.12
0.38
-3.64
-0.91
Basic Average Shares
-
1,110,000
1,102,000
1,095,000
1,091,000
Diluted Average Shares
-
1,110,000
1,107,000
1,095,000
1,091,000
Total Operating Income as Reported
-1,081,000
-2,099,000
1,716,000
-3,572,000
-443,000
Total Expenses
12,467,000
12,235,000
12,779,000
13,601,000
14,167,000
Net Income from Continuing & Discontinued Operation
-2,234,000
-2,353,000
417,000
-3,990,000
-999,000
Normalized Income
-113,600
1,514,840
1,424,760
2,246,160
1,657,800
Interest Expense
990,000
966,000
1,058,000
963,000
822,000
Net Interest Income
-1,051,000
-966,000
-1,058,000
-963,000
-822,000
EBIT
-1,116,000
-2,099,000
1,716,000
-3,443,000
-443,000
EBITDA
115,000
-791,000
3,046,000
-1,886,000
-27,000
Reconciled Cost of Revenue
8,200,000
7,952,000
8,284,000
8,933,000
9,351,000
Reconciled Depreciation
1,231,000
1,308,000
1,330,000
1,557,000
416,000
Net Income from Continuing Operation Net Minority Interest
-2,234,000
-2,353,000
417,000
-3,990,000
-999,000
Total Unusual Items Excluding Goodwill
-3,534,000
-4,896,000
-1,482,000
-6,496,000
-3,240,000
Total Unusual Items
-3,534,000
-4,896,000
-1,482,000
-6,496,000
-3,240,000
Normalized EBITDA
3,649,000
4,105,000
4,528,000
4,610,000
3,213,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,413,600
-1,028,160
-474,240
-259,840
-583,200
Advertisement
Advertisement